These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9509566)

  • 21. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy.
    Jeffers BW; Estacio RO; Raynolds MV; Schrier RW
    Kidney Int; 1997 Aug; 52(2):473-7. PubMed ID: 9264004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.
    Marre M; Bernadet P; Gallois Y; Savagner F; Guyene TT; Hallab M; Cambien F; Passa P; Alhenc-Gelas F
    Diabetes; 1994 Mar; 43(3):384-8. PubMed ID: 8314010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus.
    van Ittersum FJ; de Man AM; Thijssen S; de Knijff P; Slagboom E; Smulders Y; Tarnow L; Donker AJ; Bilo HJ; Stehouwer CD
    Nephrol Dial Transplant; 2000 Jul; 15(7):1000-7. PubMed ID: 10862638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance.
    Kuramoto N; Iizuka T; Ito H; Yagui K; Omura M; Nozaki O; Nishikawa T; Tsuchida H; Makino H; Saito Y; Kanatsuka A
    Am J Kidney Dis; 1999 Feb; 33(2):276-81. PubMed ID: 10023638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes.
    Schmidt S; Ritz E
    Nephrol Dial Transplant; 1997; 12 Suppl 2():37-41. PubMed ID: 9269698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type II exist?].
    Strojek K; Grzeszczak W; Rudzki H; Pokrzywnicki W; Lacka B; Schmidt S; Ritz E
    Pol Arch Med Wewn; 1995 Sep; 94(3):214-8. PubMed ID: 8596758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus.
    Miura J; Uchigata Y; Yokoyama H; Omori Y; Iwamoto Y
    Diabetes Res Clin Pract; 1999 Aug; 45(1):41-9. PubMed ID: 10499884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Mizuiri S; Hemmi H; Inoue A; Yoshikawa H; Tanegashima M; Fushimi T; Ishigami M; Amagasaki Y; Ohara T; Shimatake H
    Nephron; 1995; 70(4):455-9. PubMed ID: 7477652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary factors in the development of diabetic renal disease.
    Marre M; Hadjadj S; Bouhanick B
    Diabetes Metab; 2000 Jul; 26 Suppl 4():30-6. PubMed ID: 10922971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
    Arfa I; Abid A; Nouira S; Elloumi-Zghal H; Malouche D; Mannai I; Zorgati MM; Ben Alaya N; Rebai A; Zouari B; Ben Ammar S; Ben Rayana MC; Hmida S; Blousa-Chabchoub S; Abdelhak S
    J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):32-6. PubMed ID: 18404607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics.
    Azar ST; Zalloua PA; Medlej R; Halabi G
    Endocr Res; 2001; 27(1-2):99-108. PubMed ID: 11428725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate.
    Solini A; Giacchetti G; Sfriso A; Fioretto P; Sardu C; Saller A; Tonolo G; Maioli M; Mantero F; Nosadini R
    Am J Kidney Dis; 1999 Dec; 34(6):1002-9. PubMed ID: 10585308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients.
    Oh TG; Shin CS; Park KS; Kim SY; Cho BY; Lee HK; Koh CS
    Korean J Intern Med; 1996 Jun; 11(2):133-7. PubMed ID: 8854649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes.
    Wong TY; Chan JC; Poon E; Li PK
    Am J Kidney Dis; 1999 Jun; 33(6):1064-70. PubMed ID: 10352194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
    Penno G; Chaturvedi N; Talmud PJ; Cotroneo P; Manto A; Nannipieri M; Luong LA; Fuller JH
    Diabetes; 1998 Sep; 47(9):1507-11. PubMed ID: 9726242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.
    Schmidt S; Schöne N; Ritz E
    Kidney Int; 1995 Apr; 47(4):1176-81. PubMed ID: 7783416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.
    Hadjadj S; Belloum R; Bouhanick B; Gallois Y; Guilloteau G; Chatellier G; Alhenc-Gelas F; Marre M
    J Am Soc Nephrol; 2001 Mar; 12(3):541-549. PubMed ID: 11181802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M; Zibar L; Glavas-Obrovac- L; Stefanić M; Avdicević M; Barbić J
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between angiotensin-converting enzyme insertion/deletion polymorphism and proliferative retinopathy in type 2 diabetes.
    Feghhi M; Nikzamir A; Esteghamati A; Farahi F; Nakhjavani M; Rashidi A
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e1-4. PubMed ID: 18541327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.